Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What’s the Deal With These Five Stocks Trading in Red on Tuesday?

The Dow Jones index is flat and the S&P 500 and NASDAQ index are modestly in the red, amid reports that the International Monetary Fund cut its global growth outlook for the next two years on the back of Brexit-related uncertainty in the European Union. The IMF now forecasts a global growth of 3.1% this year and 3.4% in 2017, both figures having been cut by 0.1 percentage points.

Meanwhile, five companies, SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN), Ryerson Holding Corp (NYSE:RYI), Skypeople Fruit Juice Inc (NASDAQ:SPU), Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), and Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) are registering declines significantly below the market. In this article, we analyze why traders are selling and see what the funds that we track at Insider Monkey think about the companies in question.

Through extensive research, we determined that imitating some of the picks of hedge funds and other institutional investors can help generate market-beating returns over the long run. The key is to focus on the small-cap picks of these investors, since they are usually less followed by the broader market and are less price-efficient. Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see the details here).

wireless, telecoms, antenna, tower, broadcasting, station, cellular, building, sky, steel, telephone, technology, equipment, electromagnetic, mobile, architecture, transmitter


SciClone Updates on Strategic Review

SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) shares have retreated by 16% today after the company provided an update on its strategic review process previously announced in February. According to the update, SciClone is ‘no longer continuing active discussions with potential acquirers’ and SciClone plans to remain an independent company. None of the bids under discussion during the strategic review process with interested parties were at a premium to the SciClone’s recent unaffected trading price. For 2016, management expects non-GAAP EPS of $0.70 to $0.74 on revenue of $158 million to $163 million. Jim Simons’ Renaissance Technologies raised its stake in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) by 60% to 932,300 shares during the first quarter.

Follow Sciclone Pharmaceuticals Inc (NASDAQ:SCLN)
Trade (NASDAQ:SCLN) Now!

Ryerson Drops on Offering

Ryerson Holding Corp (NYSE:RYI) is almost 12% in the red today after the company commenced an underwritten public offering of 5 million shares of common stock. The company has also granted the underwriters the customary 30 day option to buy an additional 750,000 shares. Ryerson intends to use the net proceeds to reduce debt. Just three funds from our database owned $2.52 million worth of Ryerson Holding Corp (NYSE:RYI) shares, which accounted for 1.40% of the float on March 31.

On the next page, we find out why traders are selling Skypeople Fruit Juice, Ballard Power Systems, and Telefonaktiebolaget LM Ericsson.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.